HLVX vs VRCA
Comparison between HilleVax Inc (HLVX, Company) and Verrica Pharmaceuticals Inc (VRCA, Company).
Both HLVX and VRCA are from the Healthcare sector.
HLVX vs VRCA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
HLVX
$105M
VRCA
$104M
Max Drawdown
Winner
HLVX
93.71%
VRCA
98.39%
Sharpe Ratio
HLVX
0.44
Winner
VRCA
0.59
5Y Beta
HLVX
N/A
VRCA
0.57
Industry
HLVX
Biotechnology
VRCA
Biotechnology
P/E Ratio
HLVX
-1.45
Winner
VRCA
-5.82
Debt to Equity
HLVX
0.00%
VRCA
0.00%
Free Cash Flow Yield
HLVX
-57.13%
Winner
VRCA
-13.56%
P/S Ratio
HLVX
N/A
VRCA
2.66
P/B Ratio
Winner
HLVX
0.71
VRCA
6.16
HLVX vs VRCA - Historical Returns
Returns include dividend reinvestment.
1M
Winner
HLVX
+1.46%
VRCA
-3.30%
3M
HLVX
+12.97%
Winner
VRCA
+15.38%
6M
Winner
HLVX
+18.08%
VRCA
-26.96%
1Y
Winner
HLVX
+15.47%
VRCA
+3.38%
5Y(CAGR)
HLVX
N/A
VRCA
-42.49%
Max(CAGR)
HLVX
-47.96%
Winner
VRCA
-34.30%
HLVX vs VRCA - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | HLVX | VRCA |
|---|---|---|
| 2026 | N/A | -25.90% |
| 2025 | +0.48% | +18.27% |
| 2024 | -86.39% | -89.72% |
| 2023 | +6.29% | +154.17% |
| 2022 | -12.36% | -71.02% |
| 2021 | N/A | -23.92% |
| 2020 | N/A | -24.57% |
| 2019 | N/A | +99.87% |
| 2018 | N/A | -53.43% |
HLVX vs VRCA Drawdown Comparison
The maximum drawdown for HLVX was -93.71%, occurring on Apr 1, 2025. This drawdown has not yet recovered.
The maximum drawdown for VRCA was -98.39%, occurring on Nov 4, 2025. This drawdown has not yet recovered.
The current HLVX drawdown is -90.50%. The current VRCA drawdown is -96.98%.
| Rank | HLVX | VRCA |
|---|---|---|
| #1 | -93.71% Sep 13, 2022 - Apr 1, 2025 | -98.39% Jun 25, 2018 - Nov 4, 2025 |
| #2 | -56.89% May 3, 2022 - Sep 13, 2022 | -1.04% Jun 20, 2018 - Jun 25, 2018 |
Correlation
Correlation between HLVX and VRCA is 0.70 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.70
-101
Select Stocks to Compare
Popular: HLVX vs SPYVRCA vs SPY
More Comparisons
Compare with similar stocks